Pfizer Can't Escape Neurontin Antitrust MDL
A New Jersey federal judge on Thursday refused Pfizer Inc.'s bid to squash a multidistrict litigation accusing the pharmaceutical giant of conspiring to bar competition for its epilepsy treatment Neurontin and...To view the full article, register now.
Already a subscriber? Click here to view full article